S&P 500 Boosts Lululemon; Pfizer Lowers Profits, Revenue Outlook
- October 13th, 2023
- 446 views
Lululemon Athletica Inc. (Nasdaq: LULU), a notable athletic apparel company, will replace Activision Blizzard Inc. (Nasdaq: ATVI) in the S&P 500 index, effective at the opening of trading on Wednesday, October 18.
The S&P 500 is widely recognized as a benchmark for the U.S. stock market, comprising 500 leading companies with significant market capitalization. As a constituent of the S&P 500, Lululemon Athletica will represent its industry among other major sectors.
$LULU was trading at $395.88 in after-hours, up $18.18 (4.81%) following the announcement.
In other news, Pfizer Inc. (NYSE: PFE) is revising its guidance. Solely from its COVID products, the pharmaceutical giant now expects its full-year 2023 revenues to fall between $58.0 billion and $61.0 billion, down from the prior guidance range of $67.0 billion to $70.0 billion. As a result, Pfizer now expects adjusted diluted earnings per share (EPS) to range from $1.45 to $1.65, compared to the initial EPS range of $3.25 to $3.45 for the period
In after-hours, $PFE was trading at $31.03, down $1.08 (-3.36%)
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Earnings Countdown: Lockheed Martin, Stryker, and PACCAR Gear Up
January 26th, 2025Earnings Spotlight: SoFi Technologies, Sanmina, and Nucor Set to Report
January 26th, 2025Global Flag Football League Plans To Host Pro Flag Football Tournament in Las Vegas
January 23rd, 2025Earnings On Deck: Netflix, United Airlines, and Agilysys Gear Up
January 19th, 2025
Member Login